Elżbieta Iskierka-Jażdżewska

11PUBLICATIONS
86CO-AUTHORS
Respiratory diseasesCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursMedical mycologyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Aug 10, 2026
Efficacy and tolerability of venetoclax plus rituximab in relapsed or refractory chronic lymphocytic leukemia - real-world analysis of Polish adult leukemia study group.

|Nov 27, 2025
The Development of Novel Therapies for Chronic Lymphocytic Leukaemia in the Era of Targeted Drugs.

Tadeusz Robak, Elżbieta Iskierka-Jażdżewska, Anna Puła

|Aug 20, 2025
Patient-reported outcomes in relapsed/refractory diffuse large B-cell lymphoma with odronextamab monotherapy.

Elżbieta Iskierka-Jażdżewska, Won Seog Kim, Seok-Goo Cho

|Aug 01, 2025
Venetoclax and obinutuzumab in first-line treatment of unfit patients with CLL - real-life data analysis of the Polish Adult leukemia group.

Klaudia Zielonka, Błażej Izdebski, Joanna Drozd-Sokołowska

|Jan 27, 2025
Pneumonia in patients with chronic lymphocytic leukemia treated with venetoclax-based regimens: A real-world analysis of Polish Adult Leukemia Group (PALG).

Elżbieta Kalicińska, Paula Jablonowska-Babij, Marta Morawska

|May 27, 2023
Polymorphisms within Autophagy-Related Genes as Susceptibility Biomarkers for Multiple Myeloma: A Meta-Analysis of Three Large Cohorts and Functional Characterization.

Esther Clavero, José Manuel Sanchez-Maldonado, Angelica Macauda

Pageof 2

Frequent Collaborators

4 joint publications

Bartosz Puła

4 joint publications

Tadeusz Robak

3 joint publications

Federico Canzian

3 joint publications

Edyta Subocz